LabConnect Partners with Kits4Life to Reduce Kit Waste and Advance Sustainable Clinical Trials
Comunicato Precedente
Comunicato Successivo
LabConnect's ESG strategy focuses on transforming clinical trials into a more sustainable and inclusive global enterprise. From carbon footprint reduction to ethical sourcing and community engagement, we are integrating environmental and social responsibility across the full lifecycle of clinical research. Our work with Kits4Life is one more way we are turning strategy into action—by diverting valuable materials from waste streams and redirecting them to improve lives.
"We believe that sustainability and scientific innovation are not mutually exclusive—they are mutually reinforcing. As the clinical research industry evolves, partnerships like this help chart a path forward where environmental responsibility and breakthrough therapies go hand in hand," adds Tarasenko.
About LabConnect
LabConnect is the leading provider of Central Laboratory Services, FSP and Scientific Consulting, and Data Integration and Transformation Services for analytically and logistically complex studies such as immuno-oncology, cell and gene therapies, and rare & orphan diseases.
LabConnect's unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets, and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory service needs.
Learn more at www.labconnect.com and follow on LinkedIn.
Logo - https://mma.prnewswire.com/media/2611513/LabConnect_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/labconnect-partners-with-kits4life-to-reduce-kit-waste-and-advance-sustainable-clinical-trials-302524563.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




